139 related articles for article (PubMed ID: 9551228)
1. Endocrine tumours.
Lamberts SW
Cancer Chemother Biol Response Modif; 1997; 17():492-503. PubMed ID: 9551228
[No Abstract] [Full Text] [Related]
2. Endocrine tumors.
Averbuch SD
Cancer Chemother Biol Response Modif; 1991; 12():491-508. PubMed ID: 1681844
[No Abstract] [Full Text] [Related]
3. Endocrine tumors.
Lamberts SW
Cancer Chemother Biol Response Modif; 1999; 18():388-93. PubMed ID: 10800494
[No Abstract] [Full Text] [Related]
4. Chemotherapy of endocrine malignancies: a review.
Kvols LK; Buck M
Semin Oncol; 1987 Sep; 14(3):343-53. PubMed ID: 2820064
[No Abstract] [Full Text] [Related]
5. The role of somatostatin analogues in the treatment of neuroendocrine tumours.
Grozinsky-Glasberg S; Grossman AB; Korbonits M
Mol Cell Endocrinol; 2008 May; 286(1-2):238-50. PubMed ID: 18037561
[TBL] [Abstract][Full Text] [Related]
6. The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors.
Ye L; Santarpia L; Gagel RF
Endocr Rev; 2010 Aug; 31(4):578-99. PubMed ID: 20605972
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural and functional relationships of some human endocrine tumors.
Gould VE; Benditt EP
Pathol Annu; 1973; 8():205-30. PubMed ID: 4364440
[No Abstract] [Full Text] [Related]
8. Neuroendocrinomas and neuroendocrine carcinomas: APUD cell system neoplasms and their aberrant secretory activities.
Gould VE
Pathol Annu; 1977; 12 Pt 2():33-62. PubMed ID: 202912
[No Abstract] [Full Text] [Related]
9. Endocrine tumors.
Lamberts SW
Cancer Chemother Biol Response Modif; 1994; 15():521-30. PubMed ID: 7779597
[No Abstract] [Full Text] [Related]
10. [Clinical demonstrations].
Labhart A
Schweiz Med Wochenschr; 1974 Dec; 104(50):1830-41. PubMed ID: 4374744
[No Abstract] [Full Text] [Related]
11. [Endocrine polyadenomatosis: current diagnostic approach].
Lambert AE
Bull Mem Acad R Med Belg; 1986; 141(3-4):251-9. PubMed ID: 2877695
[No Abstract] [Full Text] [Related]
12. [Multiple endocrinopathies].
Schwarz F
Ned Tijdschr Geneeskd; 1982 Mar; 126(11):477-82. PubMed ID: 6123087
[No Abstract] [Full Text] [Related]
13. Aggressive trends in endocrine surgery.
Paloyan E
Surg Annu; 1970; 2(0):309-26. PubMed ID: 4368390
[No Abstract] [Full Text] [Related]
14. Systemic therapies for malignant pheochromocytoma and paraganglioma can exacerbate hypertension.
Fishbein L; Cohen DL
J Clin Hypertens (Greenwich); 2013 Jul; 15(7):513-4. PubMed ID: 23815541
[No Abstract] [Full Text] [Related]
15. The role of pre-operative α-blockade in patients with normotensive phaeochromocytoma or paraganglioma: A retrospective cohort study.
Kong H; Li N; Li XY; Wang DX
Eur J Anaesthesiol; 2018 Nov; 35(11):898-899. PubMed ID: 30278035
[No Abstract] [Full Text] [Related]
16. [Sudden death in a case of latent pheochromocytoma due to sulpiride].
Plans C; Tallada N; Yetano V; Morera J
Rev Clin Esp; 1979 Feb; 152(4):327-9. PubMed ID: 451312
[No Abstract] [Full Text] [Related]
17. Chemotherapeutic management of the hormone-secreting endocrine malignancies.
Schein PS
Cancer; 1972 Dec; 30(6):1616-26. PubMed ID: 4345099
[No Abstract] [Full Text] [Related]
18. [Antiangiogenic therapy of malignant pheochromocytoma and paraganglioma with the view to the recent scientific developments].
Kukla U; Łabuzek K; Chronowska J; Bobrzyk M; Madej P; Okopień B
Pol Merkur Lekarski; 2015 Apr; 38(226):191-5. PubMed ID: 25938384
[TBL] [Abstract][Full Text] [Related]
19. Malignant pheochromocytoma and paraganglioma: three cases illustrating the use of molecular targeted diagnostics and therapy and possible role of new drugs.
Zukauskaite R; Hjorthgau K; Poulsen PL; Baerentzen S; Ladekarl M
Acta Oncol; 2011 Nov; 50(8):1255-9. PubMed ID: 21714698
[No Abstract] [Full Text] [Related]
20. Endocrine tumors.
Lamberts SW
Cancer Chemother Biol Response Modif; 1996; 16():511-23. PubMed ID: 8639399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
